Galmed Pharmaceuticals (GLMD) Institutional Ownership $1.38 +0.02 (+1.47%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.38 +0.00 (+0.29%) As of 04/17/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Galmed Pharmaceuticals (NASDAQ:GLMD)CurrentInstitutional OwnershipPercentage76.14%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$81.03KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$808.57K Get GLMD Insider Trade Alerts Want to know when executives and insiders are buying or selling Galmed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GLMD Institutional Buying and Selling by Quarter Galmed Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025Schonfeld Strategic Advisors LLC25,400$81K0.0%N/A3.969% 5/7/2024CVI Holdings LLC74,665$25K0.0%-72.3%1.479% 8/15/2023BVF Inc. IL89,853$261K0.0%-93.3%5.348% 5/16/2023BVF Inc. IL1,347,755$575K0.0%-22.5%5.348% 7/18/2022Western Wealth Management LLC59,074$38K0.0%N/A0.235% 2/8/2022Raymond James & Associates203,540$370K0.0%-11.4%0.811% 2/7/2022Ibex Investors LLC874,144$1.59M0.5%-26.7%3.485% 11/16/2021Squarepoint Ops LLC25,404$71K0.0%-22.2%0.101% 11/16/2021Toroso Investments LLC24,657$69K0.0%N/A0.098% 11/5/2021Ibex Investors LLC1,193,100$3.33M0.7%-2.3%4.756% 11/2/2021Raymond James Financial Services Advisors Inc.21,304$59K0.0%+27.2%0.085% 11/2/2021Raymond James & Associates229,640$641K0.0%+10.5%0.915% 8/16/2021Squarepoint Ops LLC32,634$99K0.0%-40.5%0.130% 8/16/2021Nantahala Capital Management LLC944,631$2.87M0.1%-22.2%3.766% 8/16/2021Ibex Investors LLC1,220,794$3.71M1.3%-19.9%4.867% 8/5/2021Ibex Investors LLC1,220,794$3.71M1.3%-19.9%4.868% 7/31/2021 Brave Asset Management Inc.11,470$35K0.0%N/A0.046% 5/19/2021Squarepoint Ops LLC54,884$188K0.0%+161.2%0.219% 5/17/2021Goldman Sachs Group Inc.26,419$91K0.0%N/A0.105% 5/14/2021Nantahala Capital Management LLC1,213,540$4.16M0.1%-37.0%4.838% 5/13/2021Renaissance Technologies LLC60,700$208K0.0%-47.6%0.242% 3/26/2021Susquehanna International Group LLP10,483$33K0.0%N/A0.042% 2/16/2021Squarepoint Ops LLC21,010$65K0.0%-12.5%0.100% (Data available from 1/1/2016 forward) GLMD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GLMD shares? During the previous two years, the following institutional investors and hedge funds held shares of Galmed Pharmaceuticals shares: BVF Inc. IL ($261K), and Schonfeld Strategic Advisors LLC ($81K), CVI Holdings LLC ($25K).Learn more on GLMD's institutional investors. What percentage of Galmed Pharmaceuticals stock is owned by institutional investors? 76.14% of Galmed Pharmaceuticals stock is owned by institutional investors. Learn more on GLMD's institutional investor holdings. Which institutional investors have been buying Galmed Pharmaceuticals stock? The following institutional investors have purchased Galmed Pharmaceuticals stock in the last 24 months: Schonfeld Strategic Advisors LLC ($25.40K). How much institutional buying is happening at Galmed Pharmaceuticals? Institutional investors have bought a total of 25,400 shares in the last 24 months. This purchase volume represents approximately $81.03K in transactions. Which Galmed Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Galmed Pharmaceuticals stock in the last 24 months: BVF Inc. IL ($1.65M), and CVI Holdings LLC ($194.57K). How much institutional selling is happening at Galmed Pharmaceuticals? Institutional investors have sold a total of 1,844,390 shares in the last 24 months. This volume of shares sold represents approximately $74.82M in transactions. Related Companies GELS Institutional Ownership NXTC Institutional Ownership TSBX Institutional Ownership APRE Institutional Ownership CARM Institutional Ownership ACXP Institutional Ownership KPRX Institutional Ownership CHRO Institutional Ownership PMCB Institutional Ownership CYCN Institutional Ownership This page (NASDAQ:GLMD) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galmed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GLMD Stock Free GLMD Stock Alerts